Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 2,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pregnancy Clear all

Conditions: Contraception
Interventions: SHINE intervention group; Behavioral
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Pregnancy
Interventions: Encapsulated Calcium, Non-capsulated Calcium; Dietary Supplement
Lead sponsor: The Hospital for Sick Children; Other
Eligibility: 18 Years to 30 Years · Female only
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 2
States / cities: Baltimore, Maryland • Houston, Texas

Conditions: Rheumatoid Arthritis
Interventions: No Interventions; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2019
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Renal Transplant Recipient
Interventions: Belatacept, Abatacept; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Asthma, Pregnancy
Interventions: Not listed
Lead sponsor: Linnea Polgreen; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Periodontal Disease, Periapical Disease, Pregnancy, Diabetes, Cardiovascular Disease, Dental Caries
Interventions: Not listed
Lead sponsor: Roger Johnson; Other
Eligibility: 10 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Treponema Pallidum, Treponema Pallidum Infection, Syphilis Infection, Serum, Plasma, Blooddraw, Sexually Transmitted Infection (STI)
Interventions: ALPCO Syphilis-T, ALPCO Syphilis-NT CLIA Kits; Device
Lead sponsor: American Laboratory Products Company; Industry
Eligibility: 13 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 6
States / cities: Lancaster, California • Los Angeles, California • North Miami, Florida + 3 more

Conditions: Morning Sickness, Pregnancy Early
Interventions: Citrus-Based Aromatherapy, Mint-Based Aromatherapy, Spice-Scented Aromatherapy, Control; Other
Lead sponsor: Nutraceuticals Research Institute; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Franklin, Tennessee

Conditions: High Risk Pregnancy
Interventions: MRI, MRI - IUGR; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 52 Years · Female only
Enrollment: 379 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Portland, Oregon • Salt Lake City, Utah

Conditions: Weight Loss, Postpartum Weight Retention, Hypertension in Pregnancy, Diabetes Mellitus in Pregnancy, Preeclampsia, Recruitment
Interventions: Online Behavioral Weight Loss Program, Virtual weigh-in; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Opioid Use Disorder, Pregnancy Related
Interventions: Buprenorphine/ Methadone exposure; Drug
Lead sponsor: Ilana Hull; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Obesity
Interventions: Lifestyle intervention, Health education control, Individual, All Groups; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 75 Years
Enrollment: 631 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 14
States / cities: Bronson, Florida • Bunnell, Florida • Cross City, Florida + 11 more

Conditions: Placenta Accreta, Postpartum Hemorrhage, Cesarean Section, Tranexamic Acid
Interventions: Tranexamic Acid, Placebo Drug; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Fresno, California

Conditions: Infertility
Interventions: Midcycle ultrasound + hCG injection, Urinary LH kits; Other
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years to 39 Years · Female only
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Hyperglycemia in Pregnant Diabetic Patients
Interventions: insulin pre-treatment; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Language Development
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: Up to 18 Months
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Reproductive Health
Interventions: OKQ Training Program; Behavioral
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 143 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Pregnancy
Interventions: Clearblue pregnancy test; Diagnostic Test
Lead sponsor: SPD Development Company Limited; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 204 participants
Timeline: 2019
U.S. locations: 1
States / cities: Cypress, California

Conditions: Respiratory Distress Syndrome
Interventions: MIST surfactant; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: Up to 48 Hours
Enrollment: 262 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Type 1 Diabetes Mellitus, Pregnancy in Diabetes
Interventions: Hybrid closed-loop therapy, Sensor-augmented pump therapy; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Aurora, Colorado • Columbus, Ohio

Conditions: Behavior and Behavior Mechanisms, Information Literacy
Interventions: Education + Activities, Information; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 83 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Contraception
Interventions: Relugolix Combination Therapy; Drug
Lead sponsor: Sumitomo Pharma Switzerland GmbH; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 1,164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 109
States / cities: Mobile, Alabama • Chandler, Arizona • Mesa, Arizona + 89 more

Conditions: Preterm Premature Rupture of Membranes
Interventions: indomethacin; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 15 Years to 50 Years · Female only
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Type 2 Diabetes Mellitus (T2DM), Pregnancy
Interventions: CGM; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 564 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 7
States / cities: Birmingham, Alabama • San Diego, California • Chapel Hill, North Carolina + 4 more

Search by objective public record fields.

Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)

Encapsulated Calcium Absorption in Pregnancy

Abatacept Pregnancy Exposure Registry

Abatacept Conversion in Kidney Transplantation

Asthma in Pregnancy

Periodontal and Periapical Inflammation and Pregnancy

This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.

The Effect of Scent on Pregnancy Induced Nausea, Vomiting, and Quality of Life

Placenta Imaging Project

Postpartum Weight Loss for Women at Elevated Cardiovascular Risk

Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy

Rural Lifestyle Eating and Activity Program (Rural LEAP)

Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study

Use of High Cost Monitoring During Letrozole Ovulation Induction

Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients

Language Development in Preterm Children

One Key Question: Pilot Study at NorthShore

Clearblue Pregnancy Test - Lay User Study

Non Inferiority Trial Investigating Surfactants Administered Via MIST

Pregnancy Intervention With a Closed-Loop System (PICLS) Study

A Women-Focused PrEP Intervention

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy

Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM)

CGM for Management of Type 2 Diabetes in Pregnancy